Used as a chiral intermediate in the synthesis of pharmaceuticals, particularly in the production of active pharmaceutical ingredients (APIs) that require high enantiomeric purity. Its structure supports the development of neurologically active compounds, including those targeting central nervous system disorders. Commonly employed in asymmetric synthesis due to the presence of a stereogenic center, enabling selective formation of desired enantiomers in drug manufacturing processes. Also utilized in the preparation of pyrrolidine-based bioactive molecules with potential applications in treating cognitive and psychiatric conditions.